Vital Therapies (VTL US)

Immunic, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops pipeline for oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Immunic serves customers worldwide.